Astera Labs, Inc. (NASDAQ:ALAB) Receives $192.89 Consensus Target Price from Brokerages

Astera Labs, Inc. (NASDAQ:ALAB) has been assigned an average rating of “Moderate Buy” from the twenty-one analysts that are covering the firm, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $192.8889.

Several analysts recently weighed in on ALAB shares. Royal Bank Of Canada assumed coverage on Astera Labs in a research note on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 price target on the stock. Barclays set a $165.00 target price on Astera Labs in a research note on Thursday, January 15th. Weiss Ratings restated a “hold (c-)” rating on shares of Astera Labs in a report on Wednesday, January 21st. JPMorgan Chase & Co. upped their price target on shares of Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 5th. Finally, Northland Securities increased their price objective on shares of Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a research report on Tuesday, December 9th.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $129.68 on Thursday. Astera Labs has a 1 year low of $47.13 and a 1 year high of $262.90. The firm has a market cap of $21.90 billion, a price-to-earnings ratio of 106.30, a PEG ratio of 2.55 and a beta of 1.50. The company has a 50-day moving average of $160.40 and a 200 day moving average of $174.33.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. The business had revenue of $270.58 million for the quarter, compared to analyst estimates of $249.46 million. During the same quarter in the previous year, the firm posted $0.37 earnings per share. Astera Labs’s quarterly revenue was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, equities analysts anticipate that Astera Labs will post 0.34 EPS for the current year.

More Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Zacks highlights rising AI connectivity demand and Astera’s expansion of NVLink and Scorpio product lines, framing a multiyear market opportunity that could support revenue growth. ALAB Rides on Strong Connectivity Demand
• Positive Sentiment: Seeking Alpha notes strong fundamentals: revenue more than doubled YoY, very healthy free cash flow margins (>30%), roughly $1.19B cash and no debt — giving Astera flexibility to invest or absorb near‑term headwinds. The Great Astera Labs Reset
• Positive Sentiment: Recent quarterly results beat expectations (EPS and revenue) and management set Q1 2026 guidance; continued demand for high‑speed interconnects supports the growth narrative. Earnings & Guidance
• Neutral Sentiment: Reported short-interest data is effectively immaterial/odd (reported as zero), so short‑pressure does not explain intraday moves — it’s a non‑factor for current trading dynamics. Short Interest Report
• Negative Sentiment: CEO sale: Jitendra Mohan sold 94,971 shares at ~$123.81 (~$11.8M), trimming his stake by ~6.14% — a sizeable single‑day sale that can be viewed negatively by investors. CEO Form 4
• Negative Sentiment: COO sale: Sanjay Gajendra sold 94,971 shares at ~$123.81 (~$11.8M), reducing his holding by ~5.84% — another large insider disposition on the same date that amplifies concern. COO Form 4
• Negative Sentiment: CFO sale: Michael Truett Tate sold 12,001 shares at ~$123.81 (~$1.49M), lowering his stake by ~5.88% — adds to the cluster of senior‑level selling. CFO Form 4
• Negative Sentiment: General Counsel sale: Philip Mazzara sold 4,849 shares at ~$123.80 (~$600k), a smaller but concurrent insider reduction — multiple senior officers selling the same day increases perceived signal of liquidity taking or diversification. GC Form 4

Insider Activity

In related news, COO Sanjay Gajendra sold 94,971 shares of the company’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51. Following the transaction, the chief operating officer directly owned 1,531,301 shares of the company’s stock, valued at approximately $189,590,376.81. This represents a 5.84% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Manuel Alba sold 150,000 shares of Astera Labs stock in a transaction on Monday, December 1st. The stock was sold at an average price of $166.18, for a total value of $24,927,000.00. Following the completion of the sale, the director directly owned 1,574,498 shares of the company’s stock, valued at approximately $261,650,077.64. The trade was a 8.70% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 389,792 shares of company stock valued at $56,013,809. Company insiders own 12.50% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

Several institutional investors have recently modified their holdings of the business. Vanguard Group Inc. lifted its stake in Astera Labs by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after acquiring an additional 84,365 shares during the period. State Street Corp raised its holdings in shares of Astera Labs by 32.5% during the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after purchasing an additional 760,358 shares during the last quarter. Geode Capital Management LLC lifted its position in Astera Labs by 4.5% during the fourth quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after purchasing an additional 104,935 shares during the period. Fred Alger Management LLC boosted its holdings in Astera Labs by 25.5% in the fourth quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock worth $321,855,000 after purchasing an additional 393,250 shares during the last quarter. Finally, Morgan Stanley grew its position in Astera Labs by 33.0% in the 4th quarter. Morgan Stanley now owns 1,934,467 shares of the company’s stock worth $321,818,000 after purchasing an additional 480,009 shares during the period. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.